Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1992 Sep;67(9):1086–1088. doi: 10.1136/adc.67.9.1086

The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis.

M M Brett 1, E J Simmonds 1, A T Ghoneim 1, J M Littlewood 1
PMCID: PMC1793633  PMID: 1417051

Abstract

We report the results of a clinical trial. Patients enrolled had serum IgG titres against Pseudomonas aeruginosa above the control range. Assignment to the observation or treatment group was by minimisation. Significant signs or symptoms in any patient prompted antipseudomonal treatment. In addition, the treatment group received antipseudomonal treatment at intervals of four months until the serum IgG titre returned to the control range. P aeruginosa was isolated intermittently from patients in the main trial. Nineteen patients were enrolled (12 observation, seven treatment). After one year in the trial changes in parameters studied, including forced expiratory volume in one second, IgG titre, serum IgG concentrations, and frequency of P aeruginosa isolation had improved in the treated group and worsened in the observation group.

Full text

PDF
1086

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brett M. M., Ghoneim A. T., Littlewood J. M. Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study. J Clin Microbiol. 1988 Aug;26(8):1565–1570. doi: 10.1128/jcm.26.8.1565-1570.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brett M. M., Ghoneim A. T., Littlewood J. M. Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection. Arch Dis Child. 1987 Apr;62(4):357–361. doi: 10.1136/adc.62.4.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brett M. M., Ghoneim A. T., Littlewood J. M. Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis. Arch Dis Child. 1986 Nov;61(11):1114–1120. doi: 10.1136/adc.61.11.1114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chrispin A. R., Norman A. P. The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol. 1974;2(2):101–105. doi: 10.1007/BF01314939. [DOI] [PubMed] [Google Scholar]
  5. Conway S. P., Miller M. G., Ramsden C., Littlewood J. M. Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin. Acta Paediatr Scand. 1985 Jan;74(1):107–113. doi: 10.1111/j.1651-2227.1985.tb10929.x. [DOI] [PubMed] [Google Scholar]
  6. Hodson M. E., Roberts C. M., Butland R. J., Smith M. J., Batten J. C. Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis. Lancet. 1987 Jan 31;1(8527):235–237. doi: 10.1016/s0140-6736(87)90062-6. [DOI] [PubMed] [Google Scholar]
  7. Jensen T., Pedersen S. S., Høiby N., Koch C. Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis. Eur J Clin Microbiol. 1987 Dec;6(6):618–622. doi: 10.1007/BF02013055. [DOI] [PubMed] [Google Scholar]
  8. Mearns M. B., Hunt G. H., Rushworth R. Bacterial flora of respiratory tract in patients with cystic fibrosis, 1950-71. Arch Dis Child. 1972 Dec;47(256):902–907. doi: 10.1136/adc.47.256.902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Pocock S. J., Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975 Mar;31(1):103–115. [PubMed] [Google Scholar]
  10. SHWACHMAN H., KULCZYCKI L. L. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child. 1958 Jul;96(1):6–15. doi: 10.1001/archpedi.1958.02060060008002. [DOI] [PubMed] [Google Scholar]
  11. Thanasekaraan V., Wiseman M. S., Rayner R. J., Hiller E. J., Shale D. J. Pseudomonas aeruginosa antibodies in blood spots from patients with cystic fibrosis. Arch Dis Child. 1989 Nov;64(11):1599–1603. doi: 10.1136/adc.64.11.1599. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES